Nano Dimension Announces Financial Results For The Second Quarter 2025
NANO DIMENSIONS LTD. | ||||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||||||||
As of June 30, 2025 and December 31, 2024 | ||||||||
(In thousands, except share data and par value amounts) (Unaudited) | ||||||||
June 30, 2025 | December 31, 2024 | |||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ | 184,545 | $ | 317,169 | ||||
Bank deposits | 253,601 | 440,790 | ||||||
Restricted deposits | 60 | 537 | ||||||
Accounts receivable, net of allowance for expected credit losses ($2,357 and $811, respectively) | 25,314 | 9,141 | ||||||
Inventory | 42,524 | 16,899 | ||||||
Other current assets | 7,840 | 4,790 | ||||||
Assets held for sale | 143,366 | - | ||||||
Total current assets | 657,250 | 789,326 | ||||||
Restricted deposits | 1,621 | 768 | ||||||
Marketable equity securities | 111,203 | 86,190 | ||||||
Property and equipment, net | 27,241 | 14,143 | ||||||
Goodwill | 33,356 | - | ||||||
Intangible assets, net | 23,672 | 2,155 | ||||||
Right-of-use assets | 32,959 | 9,958 | ||||||
Other assets | 1,536 | - | ||||||
Total assets | $ | 888,838 | $ | 902,540 | ||||
Liabilities and Stockholders' Equity | ||||||||
Current liabilities | ||||||||
Accounts payable | $ | 12,012 | $ | 4,249 | ||||
Accrued expenses | 17,518 | 18,771 | ||||||
Deferred revenue | 12,014 | 3,523 | ||||||
Short-term settlement payable | 1,000 | - | ||||||
Current portion of bank loan | 157 | 138 | ||||||
Lease liabilities | 9,519 | 3,421 | ||||||
Liabilities held for sale | 136,598 | - | ||||||
Total current liabilities | 188,818 | 30,102 | ||||||
Long-term settlement payable | 4,664 | - | ||||||
Long-term deferred revenue | 3,993 | - | ||||||
Employee benefits | 5,340 | 4,700 | ||||||
Long-term lease liabilities | 26,282 | 6,707 | ||||||
Long-term bank loan | 235 | 276 | ||||||
Total liabilities | 229,332 | 41,785 | ||||||
Commitments and contingencies | ||||||||
Stockholders' equity | ||||||||
Non-controlling interests | - | 715 | ||||||
Share capital of NIS 5 par value each; 500,000,000 ordinary shares authorized; 218,362,257 and 215,777,000 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 412,766 | 409,145 | ||||||
Share premium and capital reserves | 1,297,822 | 1,297,348 | ||||||
Treasury shares | (167,651 | ) | (167,651 | ) | ||||
Foreign currency translation reserve | 2,763 | 1,044 | ||||||
Remeasurement of net defined benefit liability | (2,181 | ) | (2,181 | ) | ||||
Accumulated loss | (884,013 | ) | (677,665 | ) | ||||
Total stockholders' equity | 659,506 | 860,755 | ||||||
Total liabilities and stockholders' equity | $ | 888,838 | $ | 902,540 | ||||
NANO DIMENSIONS LTD. |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
For the Three and Six Months ended June 30, 2025 |
(In thousands, except share data and per share data) (Unaudited) |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2025 (1) | 2024 | 2025 (1) | 2024 | ||||||||||||
Revenue | $ | 25,837 | $ | 14,986 | $ | 40,238 | $ | 28,350 | |||||||
Cost of revenue | 18,794 | 8,292 | 27,354 | 15,386 | |||||||||||
Gross profit | 7,043 | 6,694 | 12,884 | 12,964 | |||||||||||
Operating expenses | |||||||||||||||
Research and development | 8,114 | 9,580 | 14,058 | 20,146 | |||||||||||
Sales and marketing | 9,907 | 7,309 | 15,551 | 14,045 | |||||||||||
General and administrative | 22,190 | 11,200 | 27,856 | 20,541 | |||||||||||
Restructuring expense | 2,101 | - | 3,281 | - | |||||||||||
Desktop Metal litigation expense | 3,245 | - | 31,315 | - | |||||||||||
Impairment losses | 1,456 | - | 2,685 | - | |||||||||||
Total operating expenses | 47,013 | 28,089 | 94,746 | 54,732 | |||||||||||
Loss from operations | (39,970 | ) | (21,395 | ) | (81,862 | ) | (41,768 | ) | |||||||
Gain (loss) on investment in marketable equity securities | 16,288 | (31,315 | ) | 25,013 | (57,104 | ) | |||||||||
Loss from deconsolidation of subsidiaries | (1,666 | ) | - | (1,666 | ) | - | |||||||||
Other income (expense), net | (56 | ) | - | (56 | ) | - | |||||||||
Finance expense | (234 | ) | (2,324 | ) | (263 | ) | (3,521 | ) | |||||||
Finance income | 14,352 | 10,535 | 22,023 | 21,846 | |||||||||||
Loss before income taxes | (11,286 | ) | (44,499 | ) | (36,811 | ) | (80,547 | ) | |||||||
Income tax expense (benefit) | 76 | 141 | 99 | 125 | |||||||||||
Net loss from continuing operations | (11,362 | ) | (44,640 | ) | (36,910 | ) | (80,672 | ) | |||||||
Net loss from discontinued operations, net of income tax of nil | (169,761 | ) | - | (169,761 | ) | - | |||||||||
Net loss | (181,123 | ) | (44,640 | ) | (206,671 | ) | (80,672 | ) | |||||||
Loss attributable to non-controlling interests | (87 | ) | (290 | ) | (323 | ) | (480 | ) | |||||||
Loss attributable to owners | $ | (181,036 | ) | $ | (44,350 | ) | $ | (206,348 | ) | $ | (80,192 | ) | |||
Basic and diluted income (loss) per share | |||||||||||||||
Net loss per share from continuing operations - basic and diluted | $ | (0.05 | ) | $ | (0.20 | ) | $ | (0.17 | ) | $ | (0.36 | ) | |||
Net loss per share from discontinued operations - basic and diluted | $ | (0.78 | ) | $ | - | $ | (0.78 | ) | $ | - | |||||
(1) The results for the three and six months ended June 30, 2025 include the consolidation of Markforged revenue of $16.1 million, gross profit of $3.4 million, and GAAP net loss of $10.3 million.
NANO DIMENSIONS LTD. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS For the Six Months ended June 30, 2025 (In thousands) (Unaudited) | |||||||
For the Six Months Ended June 30, | |||||||
2025 | 2024 | ||||||
Cash flow from operating activities: | |||||||
Net loss from continuing operations | $ | (36,910 | ) | $ | (80,672 | ) | |
Adjustments: | |||||||
Depreciation, amortization, and non-cash lease interest | 8,282 | 1,352 | |||||
Impairment losses | 2,685 | - | |||||
Financing income, net | (21,872 | ) | (18,358 | ) | |||
Interest received | 18,580 | 22,715 | |||||
(Gain) loss from revaluation of financial assets and liabilities accounted at fair value | (24,995 | ) | 57,137 | ||||
Loss from deconsolidation of subsidiaries | 1,666 | - | |||||
Share-based payments | 1,644 | 8,455 | |||||
Other | (93 | ) | 97 | ||||
(51,013 | ) | (9,274 | ) | ||||
Changes in assets and liabilities: | |||||||
Decrease (increase) in inventory | 3,203 | (1,899 | ) | ||||
(Increase) decrease in other receivables | (772 | ) | 5,845 | ||||
(Increase) decrease in trade receivables | (914 | ) | 3 | ||||
Decrease in other payables | (7,219 | ) | (3,779 | ) | |||
Increase in employee benefits | 77 | 132 | |||||
Increase (decrease) in trade payables | 6,044 | (1,410 | ) | ||||
Net cash used in operating activities | (50,594 | ) | (10,382 | ) | |||
Cash flow from investing activities: | |||||||
Change in bank deposits | 190,466 | 5,412 | |||||
Change in restricted bank deposits | 484 | (25 | ) | ||||
Acquisition of property, plant and equipment | (461 | ) | (1,169 | ) | |||
Acquisition of intangible asset | - | (711 | ) | ||||
Acquisition of subsidiaries, net of cash acquired | (267,806 | ) | - | ||||
Deconsolidation of subsidiaries | (476 | ) | - | ||||
Net cash (used in) from investing activities | (77,793 | ) | 3,507 | ||||
Cash flow from financing activities: | |||||||
Repayment long-term bank debt | (72 | ) | (107 | ) | |||
Payments of share price protection recognized in business combination | - | (363 | ) | ||||
Repurchase of treasury shares | - | (69,755 | ) | ||||
Net cash used in financing activities | (72 | ) | (70,225 | ) | |||
Cash flows provided by (used in) discontinued operations: | |||||||
Net cash used in operating activities | (15,733 | ) | - | ||||
Net cash used in investing activities | (437 | ) | - | ||||
Net cash provided by financing activities | 10,009 | - | |||||
Net cash used in discontinued operations | (6,161 | ) | - | ||||
Decrease in cash and cash equivalents | (134,620 | ) | (77,100 | ) | |||
Cash and cash equivalents at beginning of the period | 317,169 | 309,571 | |||||
Effect of exchange rate fluctuations on cash | 1,996 | (694 | ) | ||||
Cash and cash equivalents at end of the period | $ | 184,545 | $ | 231,777 | |||
Non-cash transactions: | |||||||
Property, plant and equipment acquired on credit | - | 176 | |||||
Recognition of a right-of-use asset | 191 | 233 | |||||
Income taxes paid during the period | 36 | - | |||||
NANO DIMENSIONS LTD. | ||||||||||||||||
RECONCILIATION OF US GAAP TO NON-GAAP MEASURES | ||||||||||||||||
(In thousands) (Unaudited) | ||||||||||||||||
| Three Months Ended June 30, | | Six Months Ended June 30, | |||||||||||||
| 2025 | 2024 | | 2025 | 2024 | |||||||||||
GAAP Net loss from continuing operations | | $ | (11,362 | ) | $ | (44,640 | ) | | $ | (36,910 | ) | $ | (80,672 | ) | ||
Tax expense (benefit) | | 76 | 141 | | 99 | 125 | ||||||||||
Depreciation and amortization | 1,936 | 329 | 2,510 | 1,352 | ||||||||||||
Interest expense | 184 | - | 184 | - | ||||||||||||
Interest income | (5,944 | ) | (10,535 | ) | (15,253 | ) | (21,846 | ) | ||||||||
Non-GAAP EBITDA (loss) | (15,110 | ) | (54,705 | ) | (49,370 | ) | (101,041 | ) | ||||||||
Finance expenses (income) from revaluation of assets and liabilities | (16,263 | ) | 31,326 | (24,992 | ) | 57,137 | ||||||||||
Exchange rate differences | (8,363 | ) | 2,293 | (6,724 | ) | 3,449 | ||||||||||
Share-based payments expenses | 2,430 | 3,729 | 1,644 | 8,455 | ||||||||||||
Desktop Metal litigation related expenses | 3,245 | - | 31,315 | - | ||||||||||||
Desktop Metal and Markforged transaction related expenses | 8,304 | 2,721 | 9,820 | 2,721 | ||||||||||||
Restructuring costs | 2,101 | - | 3,281 | - | ||||||||||||
Loss from deconsolidation of subsidiaries | 1,666 | - | 1,666 | - | ||||||||||||
Impairment losses | 1,456 | - | 2,685 | - | ||||||||||||
Acquisition inventory step-up amortization | 3,849 | - | 3,849 | - | ||||||||||||
Other non-GAAP | - | - | - | (115 | ) | |||||||||||
Non-GAAP Adjusted EBITDA | | $ | (16,684 | ) | $ | (14,636 | ) | | $ | (26,826 | ) | $ | (29,394 | ) | ||
| Three Months Ended June 30, | | Six Months Ended June 30, | |||||||||||||
Non-GAAP Cost of Revenue | | 2025 | 2024 | | 2025 | 2024 | ||||||||||
GAAP Cost of revenue | | $ | 18,794 | $ | 8,292 | | $ | 27,354 | $ | 15,386 | ||||||
Stock compensation expense | | 80 | 231 | | 326 | 468 | ||||||||||
Depreciation and amortization | 578 | (22 | ) | | 719 | 52 | ||||||||||
Acquisition inventory step-up amortization | 3,849 | - | 3,849 | - | ||||||||||||
Non-GAAP Cost of revenue | $ | 14,287 | $ | 8,083 | $ | 22,460 | $ | 14,866 | ||||||||
| Three Months Ended June 30, | | Six Months Ended June 30, | |||||||||||||
Non-GAAP Gross Profit | | 2025 | 2024 | | 2025 | 2024 | ||||||||||
GAAP Gross profit | | $ | 7,043 | $ | 6,694 | | $ | 12,884 | $ | 12,964 | ||||||
Stock compensation expense | | 80 | 231 | | 326 | 468 | ||||||||||
Depreciation and amortization | 578 | (22 | ) | | 719 | 52 | ||||||||||
Acquisition inventory step-up amortization | 3,849 | - | 3,849 | - | ||||||||||||
Non-GAAP Gross profit | $ | 11,550 | $ | 6,903 | $ | 17,778 | $ | 13,484 | ||||||||
| Three Months Ended June 30, | | Six Months Ended June 30, | |||||||||||||
Non-GAAP Research and Development Expenses | | 2025 | 2024 | | 2025 | 2024 | ||||||||||
GAAP Research and development expenses | | $ | 8,114 | $ | 9,580 | | $ | 14,058 | $ | 20,146 | ||||||
Stock compensation expense | | 644 | 1,435 | | 713 | 3,369 | ||||||||||
Depreciation and amortization | 364 | 255 | | 573 | 611 | |||||||||||
Non-GAAP Research and development expenses | $ | 7,106 | $ | 7,890 | $ | 12,772 | $ | 16,166 | ||||||||
| Three Months Ended June 30, | | Six Months Ended June 30, | |||||||||||||
Non-GAAP Sales and Marketing Expenses | | 2025 | 2024 | | 2025 | 2024 | ||||||||||
GAAP Sales and marketing expenses | | $ | 9,907 | $ | 7,309 | | $ | 15,551 | $ | 14,045 | ||||||
Stock compensation expense | | 225 | 432 | | 548 | 929 | ||||||||||
Depreciation and amortization | 593 | (2 | ) | | 636 | 324 | ||||||||||
Non-GAAP Sales and marketing expenses | $ | 9,089 | $ | 6,879 | $ | 14,367 | $ | 12,792 | ||||||||
| Three Months Ended June 30, | | Six Months Ended June 30, | |||||||||||||
Non-GAAP General and Administrative Expenses | | 2025 | 2024 | | 2025 | 2024 | ||||||||||
GAAP General and administrative expenses | | $ | 22,190 | $ | 11,200 | | $ | 27,856 | $ | 20,541 | ||||||
Stock compensation expense | | 1,480 | 1,631 | | 56 | 3,689 | ||||||||||
Depreciation and amortization | 401 | 98 | | 582 | 365 | |||||||||||
Desktop Metal and Markforged transaction related expenses | 8,304 | 2,721 | 9,820 | 2,721 | ||||||||||||
Other non-GAAP | - | - | - | (115 | ) | |||||||||||
Non-GAAP General and administrative expenses | $ | 12,004 | $ | 6,750 | $ | 17,398 | $ | 13,881 | ||||||||
| Three Months Ended June 30, | | Six Months Ended June 30, | |||||||||||||
Non-GAAP Operating Loss | | 2025 | 2024 | | 2025 | 2024 | ||||||||||
GAAP Operating loss | | $ | (39,970 | ) | $ | (21,395 | ) | | $ | (81,862 | ) | $ | (41,768 | ) | ||
Stock compensation expense | | 2,429 | 3,729 | | 1,643 | 8,455 | ||||||||||
Depreciation and amortization | 1,936 | 329 | | 2,510 | 1,352 | |||||||||||
Desktop Metal litigation related expenses | 3,245 | - | 31,315 | - | ||||||||||||
Desktop Metal and Markforged transaction related expenses | 8,304 | 2,721 | 9,820 | 2,721 | ||||||||||||
Restructuring costs | 2,101 | - | 3,281 | - | ||||||||||||
Impairment losses | 1,456 | - | 2,685 | - | ||||||||||||
Acquisition inventory step-up amortization | 3,849 | - | 3,849 | - | ||||||||||||
Other non-GAAP | - | - | - | (115 | ) | |||||||||||
Non-GAAP Operating loss | $ | (16,649 | ) | $ | (14,616 | ) | $ | (26,759 | ) | $ | (29,355 | ) | ||||
DISAGGREGATED REVENUE BY NATURE OF PRODUCTS AND SERVICES | ||||||||||||||||
(In thousands) (Unaudited) | ||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||||
Hardware | $ | 16,707 | $ | 11,085 | $ | 28,180 | $ | 21,052 | ||||||||
Consumables | 5,936 | 2,460 | 7,746 | 4,645 | ||||||||||||
Services | 3,194 | 1,441 | 4,312 | 2,653 | ||||||||||||
Total Revenue | $ | 25,837 | $ | 14,986 | $ | 40,238 | $ | 28,350 |
DISAGGREGATED REVENUE BY GEOGRAPHIC LOCATION | ||||||||||||||||
(In thousands) (Unaudited) | ||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||||
Americas | $ | 10,988 | $ | 5,221 | $ | 15,747 | $ | 8,783 | ||||||||
EMEA | 11,646 | 8,316 | 19,802 | 17,288 | ||||||||||||
APAC | 3,203 | 1,449 | 4,689 | 2,279 | ||||||||||||
Total Revenue | $ | 25,837 | $ | 14,986 | $ | 40,238 | $ | 28,350 |


Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Chicago Clearing Corporation And Taxtec Announce Strategic Partnership
- Everstake Expands Institutional Solana Services With Shredstream, Swqos, And Validator-As-A-Service
- Japan Smart Cities Market Size Is Expected To Reach USD 286.6 Billion By 2033 CAGR: 14.6%
- Alchemy Markets Launches Tradingview Integration For Direct Chart-Based Trading
- Blackrock Becomes The Second-Largest Shareholder Of Freedom Holding Corp.
- Pluscapital Advisor Empowers Traders To Master Global Markets Around The Clock
Comments
No comment